Current Studies

Here is a list of some of our current studies. For additional studies, please visit RecruitMe.

  • Children with Attention-Deficit/Hyperactivity Disorder (ADHD) are typically treated with two types of medications: stimulants and non-stimulants. These medications work in different ways to treat ADHD symptoms, but we do not fully understand the brain mechanisms underlying the medications' effects. This study will use MRI scanning to look at changes in the brain associated with medication treatment of ADHD in children.
  • The purpose of this research study is to find out which antidepressants work best in individuals over the age of 60 years. We invite you to participate in this research study because you are 60+ years old have depression and your depression has not gotten better even after taking two or more medications.
  • Psilocybin is the active ingredient in some forms of psychedelic mushrooms. Its effects can include euphoria, visual hallucinations, changes in perception, a distorted sense of time and spiritual experiences. Adverse events can include headaches, rapid heart beat, increased blood pressure, nausea and panic attacks. All of these effects generally last minutes to hours, though perceptual changes occasionally recur to a lesser and lesser extent as they dissipate over several weeks.
  • The purpose of this study is to examine the use of a new portable brain imaging device to study a measure of brain activity, and to develop optimal methods for analyzing the data from this device. After baseline assessments including clinical interview, physical exam, and blood tests, participants will undergo 3 brain scans on separate days: two Positron Emission Tomography (PET) scans, each lasting one hour, using different PET cameras, to measure metabolic activity in the brain, and one Magnetic Resonance Imaging (MRI) scan, to obtain information about brain structure.
  • This study conducts behavioral tasks to explore the biological causes of depression and suicidal behavior. We hope to develop a better understanding of how people who feel depressed and suicidal cope with their feelings so we can improve treatment and prevention. Participants can have depression with or without a suicidal thoughts or any history of suicide attempts. Participation involves clinical assessments, a week-long phone survey, a stress test and computer games.
  • This study conducts behavioral tasks to explore the biological causes of depression and suicidal behavior. We hope to develop a better understanding of how people who attempt suicide differ from those who do not in order to improve prevention. Participation includes clinical assessments,a week-long phone survey, a stress test and a computer game. Eligible individuals will be compensated up to $125.
  • We are seeking individuals without any history of psychiatric disorders to serve as controls in our studies of OCD and anxiety. Studies may involve diagnostic interviews, MRI scans, and computer tasks. Compensation provided for time and travel.
  • This study uses smartphone technology to better understand changes in adolescent moods over time. As a participant in our study, we would: (a) interview your child about current and past thoughts, feelings, and behaviors and (b) collect data from your child's smartphone for 6 months through an app called the Effortless Assessment of Risk States (EARS; which would be installed during the initial study visit after you learned more about the study and provided permission).
  • This research study is testing medication strategies for weight loss in individuals with schizophrenia or schizoaffective disorder. Participants will be randomly assigned (like a coin flip) to lorcaserin, lorcserin plus metformin, or placebo. All participants will be offered regular diet and exercise counseling. The study lasts one year.
  • The Translational Medicine Program at the Center for Autism and the Developing Brain is recruiting individuals with autism from 5 17 years of age with an IQ over 70 to participate in our study called aV1ation. The purpose of this study is to test an investigational medicine that blocks a hormone receptor in the brain linked to the control of socialization, stress, anxiety and aggression. We want to see if this medicine is effective as a treatment to help improve social functioning in children with ASD.

Pages